Maintenance of Cdc42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF - Evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by Cdc42-GTP

Citation
I. Arozarena et al., Maintenance of Cdc42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF - Evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by Cdc42-GTP, J BIOL CHEM, 276(24), 2001, pp. 21878-21884
Citations number
44
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
276
Issue
24
Year of publication
2001
Pages
21878 - 21884
Database
ISI
SICI code
0021-9258(20010615)276:24<21878:MOCGSB>2.0.ZU;2-2
Abstract
The function of the Pas guanine nucleotide exchange factor Ras-GRF/cdc25(Mn ) is subject to tight regulatory processes. We have recently shown that the activation of the Ras/MAPK pathway by Ras-GRF is controlled by the Rho fam ily GTPase Cdc42 through still unknown mechanisms. Here, we report that ret aining Cdc42 in its GDP-bound state by overexpressing Rho-GDI inhibits Ras- GRF-mediated MAPK activation. Conversely, Ras-GRF basal and LPA- or ionomyc in-stimulated activities were unaffected by a constitutively active GTP-bou nd Cdc42, Moreover, the Cdc42 downstream effecters MLK3, ACK1, PAK1, and WA SP had no detectable influence on Ras-GRF-mediated MAPK activation. In cont rast, promoting GDP release from Cdc42 with the Rho family GEF Dbl or with ionomycin suppressed the restraint exerted by Cdc42 on Ras-GRF activity. We conclude that Cdc42-GDP inhibits Ras-GRF-induced MAPK activation, but neit her Cdc42-GTP nor the Cdc42 downstream effecters affect Ras-GRF performance , Interestingly, the loss of the GDP-bound state by Cdc42 abolishes its inh ibitory effects on Ras-GRF function. These results suggest that the Cdc42 m echanism of action may not be solely restricted to activation of downstream signaling cascades when GTP-loaded, Furthermore, the GDP-bound form may be acting as an inhibitory molecule down-modulating parallel signaling routes such as the Ras/MAPK pathway.